---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039557"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T20:58:21.440942+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Biotricity issues $1M convertible note with 12% interest, 18-month maturity

## Summary
- Issued $1,000,000 unsecured convertible preferred note to an investor.
- Note bears 12% annual interest, payable monthly in cash.
- Maturity 18 months; prepayable at 15% discount to 10-day VWAP; conversion at 20% discount to Qualified Financing price or 15% discount to VWAP at maturity.
- Note issued in reliance on Section 4(a)(2) exemption from registration.

## SEC filing metadata
- accession: 0001493152-23-039557
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/0001493152-23-039557-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039557
- JSON: https://secwatch.observer/filing/0001493152-23-039557.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039557.txt

## Key facts
- Debt Financings
  BIOTRICITY INC. incurred convertible notes of $1,000,000 at 12% per annum maturing the earlier of 18 months or the 18 month anniversary of the last closing date.
  - Instrument: convertible notes
  - Principal: $1,000,000
  - Rate: 12% per annum
  - Maturity: the earlier of 18 months or the 18 month anniversary of the last closing date
  - Event: incurrence
  source text: On October 31, 2023, Biotricity Inc. (the “Company”) entered into a subscription agreement (the “Agreement”) pursuant to which the Company issued an unsecured convertible preferred note (the “Note”) in the principal amount of $1,000,000 to an investor (“Investor”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/0001493152-23-039557-index.htm
- Material Agreements
  BIOTRICITY INC. entered into Agreement valued at $1,000,000 (effective 2023-10-31).
  - Action: entry
  - Agreement: notes offering
  - Value: $1,000,000
  - Effective: 2023-10-31
  source text: On October 31, 2023, Biotricity Inc. (the “Company”) entered into a subscription agreement (the “Agreement”) pursuant to which the Company issued an unsecured convertible preferred note (the “Note”) in the principal amount of $1,000,000 to an investor (“Investor”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/0001493152-23-039557-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.